Nasdaq halts trading in Silence Therapeutics pending news at 7:55 a.m.
SLN•Nasdaq halted trading in Silence Therapeutics pending news at 7:55 a.m.
Related News
Siebert Financial sees technology selloff as market rotation, not systemic panic
SIEB•
Akeso opens global Phase II trial of ivonescimab in first-line kidney cancer
SMMT•
MKS agrees to sell Ophir Optics business to TTM Technologies for $650 million
MKSI•
Low-carbon copper and aluminium products
XLB•
Nasdaq trade halt continues; reason not available at 7:55 am
TJGC•